LobbyingIchor Sciences lobbying by quarter
Ichor Sciences's latest lobbying report covers Q3 2023, at $5,000. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs.
Ichor Sciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $10K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $5,000 | 1 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$55K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Defense, Dept of (DOD)4 reports
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Strategic Marketing Innovations | $55K | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/10/18for Q3 2023 | Strategic Marketing Innovations | $5,000 |
| 23/07/17for Q2 2023 | Strategic Marketing Innovations | $20K |
| 23/04/18for Q1 2023 | Strategic Marketing Innovations | $20K |
| 23/01/17for Q4 2022 | Strategic Marketing Innovations | $10K |
| 23/01/16for Q4 2022 | Strategic Marketing Innovations | Under $5,000 |